Prosight Management’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.25M | Sell |
|
|||||
|
2023
Q1 | $3.81M | Sell |
|
|||||
|
2022
Q4 | $5.98M | Sell |
|
|||||
|
2022
Q3 | $6.47M | Sell |
|
|||||
|
2022
Q2 | $7.92M | Buy |
|
|||||
|
2022
Q1 | $6.22M | Buy |
|
|||||
|
2021
Q4 | $4.62M | Buy |
|
|||||
|
2021
Q3 | $6.45M | Buy |
|
|||||
|
2021
Q2 | $6.74M | Buy |
|
|||||
|
2021
Q1 | $5.63M | Sell |
|
|||||
|
2020
Q4 | $6.23M | Sell |
|
|||||
|
2020
Q3 | $8.09M | Sell |
|
|||||
|
2020
Q2 | $6.76M | Sell |
|
|||||
|
2020
Q1 | $5.03M | Buy |
|
|||||
|
2019
Q4 | $8.3M | Buy |
|
|||||
|
2019
Q3 | $4.17M | Buy |
|
|||||
|
2019
Q2 | $4.19M | Buy |
|
|||||
|
2019
Q1 | $5.27M | Buy |
|
|||||
|
2018
Q4 | $3.36M | Buy |
|